Advertisement

Topics

Pfizer enrolls first patient in Duchenne muscular dystrophy study

06:19 EDT 16 Apr 2018 | SmartBrief

A Phase Ib trial was launched by Pfizer for its mini-dystrophin drug candidate PF-06939926 to treat patients with Duchenne mu -More

Original Article: Pfizer enrolls first patient in Duchenne muscular dystrophy study

NEXT ARTICLE

More From BioPortfolio on "Pfizer enrolls first patient in Duchenne muscular dystrophy study"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...